Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone

Brain, Behavior, and Immunity

Volumn 69, Issue , 2018, Pages 321-335

  Dostal, Carlos R ^a   Gamsby, Nicolaus S ^a   Lawson, Marcus A ^a   McCusker, R H ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Astrocyte; Inflammation; Kynurenine; Microglia; Stress

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; IDO1 PROTEIN; IDO2 PROTEIN; INDOLEAMINE; KYNURENINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TDO2 PROTEIN; TRYPTOPHAN 2,3 DIOXYGENASE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATION; KYNURENINE PATHWAY; LIVER; LUNG; MALE; MICROGLIA; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SPLEEN; UPREGULATION; ANIMAL; DRUG EFFECT; GLIA; MENTAL STRESS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CYTOKINES; DEXAMETHASONE; GLUCOCORTICOIDS; INFLAMMATION; KYNURENINE; LIPOPOLYSACCHARIDES; MALE; MICE; NEUROGLIA; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 85039441401     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2017.12.006     Document Type: Article

References (93)

1. Agudelo, L.Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J.C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., Pettersson, A.T., Ferreira, D.M.S., Krook, A., Barres, R., Zierath, J.R., Erhardt, S., Lindskog, M., Ruas, J.L., Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159 (2014), 33–45, 10.1016/j.cell.2014.07.051.
2. André, C., O'Connor, J.C., Kelley, K.W., Lestage, J., Dantzer, R., Castanon, N., Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J. Neuroimmunol. 200 (2008), 90–99, 10.1016/j.jneuroim.2008.06.011.
3. Badawy, A.A.B., Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements. Neuropharmacology 112 (2015), 248–263, 10.1016/j.neuropharm.2015.11.015.
4. Ball, H.J., Sanchez-Perez, A., Weiser, S., Austin, C.J.D., Astelbauer, F., Miu, J., McQuillan, J.A., Stocker, R., Jermiin, L.S., Hunt, N.H., Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396 (2007), 203–213, 10.1016/j.gene.2007.04.010.
5. Ball, H.J., Yuasa, H.J., Austin, C.J.D., Weiser, S., Hunt, N.H., Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int. J. Biochem. Cell Biol. 41 (2009), 467–471, 10.1016/j.biocel.2008.01.005.
6. Berry, L.J., Smythe, D.S., Effects of bacterial endotoxins on metabolism. VI. The role of tryptophan pyrrolase in response of mice to endotoxin. J. Exp. Med. 41 (1963), 587–603, 10.1084/jem.118.4.587.
7. Bradley, K.A.L., Case, J.A.C., Khan, O., Ricart, T., Hanna, A., Alonso, C.M., Gabbay, V., The role of the kynurenine pathway in suicidality in adolescent major depressive disorder. Psychiatry Res. 227 (2015), 206–212, 10.1016/j.psychres.2015.03.031.
8. Braidy, N., Guillemin, G.J., Grant, R., Effects of kynurenine pathway inhibition on NAD + metabolism and cell viability in human primary astrocytes and neurons. Int. J. Tryptophan Res. 4 (2011), 29–37, 10.4137/IJTR.S7052.
9. Brooks, A.K., Janda, T.M., Lawson, M.A., Rytych, J.L., Smith, R.A., Ocampo-Solis, C., McCusker, R.H., Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases. Brain Behav. Immun. 62 (2017), 219–229, 10.1016/j.bbi.2017.02.010.
10. Brooks, A.K., Lawson, M.A., Rytych, J.L., Yu, K.C., Janda, T.M., Steelman, A.J., McCusker, R.H., Immunomodulatory factors galectin-9 and interferon-gamma synergize to induce expression of rate-limiting enzymes of the kynurenine pathway in the mouse hippocampus. Front. Immunol. 7 (2016), 1–16, 10.3389/fimmu.2016.00422.
11. Brooks, A.K., Lawson, M.A., Smith, R.A., Janda, T.M., Kelley, K.W., McCusker, R.H., Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus. J. Neuroinflammation 13 (2016), 1–16, 10.1186/s12974-016-0563-1.
12. Browne, C.A., O'Brien, F.E., Connor, T.J., Dinan, T.G., Cryan, J.F., Differential lipopolysaccharide-induced immune alterations in the hippocampus of two mouse strains: effects of stress. Neuroscience 225 (2012), 237–248, 10.1016/j.neuroscience.2012.08.031.
13. Capuron, L., Miller, A., Irwin, M., Psychoneuroimmunology of depressive disorder: mechanisms and clinical implications. Ader, R., (eds.) Psychoneuroimmunology, 2006, Academic Press, 509–530, 10.1016/B978-012088576-3/50030-7.
14. Couch, Y., Trofimov, A., Markova, N., Nikolenko, V., Steinbusch, H.W., Chekhonin, V., Schroeter, C., Lesch, K.-P., Anthony, D.C., Strekalova, T., Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice. J. Neuroinflammation, 13, 2016, 108, 10.1186/s12974-016-0572-0.
15. Croitoru-Lamoury, J., Lamoury, F.M.J., Caristo, M., Suzuki, K., Walker, D., Takikawa, O., Taylor, R., Brew, B.J., Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS One, 6, 2011, 10.1371/journal.pone.0014698.
16. Dantzer, R., Role of the kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches. Curr. Top. Behav. Neurosci., 2016 10.1007/7854_2016_6.
17. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56, 10.1038/nrn2297.
18. Dostal, C.R., Carson Sulzer, M., Kelley, K.W., Freund, G.G., McCusker, R.H., Glial and tissue-specific regulation of Kynurenine Pathway dioxygenases by acute stress of mice. Neurobiol. Stress 7 (2017), 1–15.
19. Dugan, A.M., Parrott, J.M., Redus, L., Hensler, J.G., O'Connor, J.C., Low-level stress induces production of neuroprotective factors in wild-type but not BDNF+/− mice: Interleukin-10 and kynurenic acid. Int. J. Neuropsychopharmacol. 19 (2016), 1–5, 10.1093/ijnp/pyv089.
20. Fu, X., Zunich, S.M., O'Connor, J.C., Kavelaars, A., Dantzer, R., Kelley, K.W., Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J. Neuroinflammation, 7, 2010, 43, 10.1186/1742-2094-7-43.
21. Fuertig, R., Azzinnari, D., Bergamini, G., Cathomas, F., Sigrist, H., Seifritz, E., Vavassori, S., Luippold, A., Hengerer, B., Ceci, A., Pryce, C.R., Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase. Brain. Behav. Immun. 54 (2016), 59–72, 10.1016/j.bbi.2015.12.020.
22. Fujigaki, S., Saito, K., Sekikawa, K., Tone, S., Takikawa, O., Fujii, H., Wada, H., Noma, A., Seishima, M., Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism. Eur. J. Immunol. 31 (2001), 2313–2318, 10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S.
23. Fujigaki, S., Saito, K., Takemura, M., Fujii, H., Wada, H., Noma, A., Seishima, M., Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes. Arch. Biochem. Biophys. 358 (1998), 329–335, 10.1006/abbi.1998.0861.
24. Fukunaga, M., Yamamoto, Y., Kawasoe, M., Arioka, Y., Murakami, Y., Hoshi, M., Saito, K., Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis. J. Histochem. Cytochem. 60 (2012), 854–860, 10.1369/0022155412458926.
25. Gibney, S.M., Fagan, E.M., Waldron, A., O'Byrne, J., Connor, T.J., Harkin, A., Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. Int. J. Neuropsychopharmacol. 17 (2014), 917–928, 10.1017/S1461145713001673.
26. Godbout, J.P., Moreau, M., Lestage, J., Chen, J., Sparkman, N.L., O'Connor, J.C., Castanon, N., Kelley, K.W., Dantzer, R., Johnson, R.W., Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 33 (2008), 2341–2351, 10.1038/sj.npp.1301649.
27. Guo, Y., Cai, H., Chen, L., Liang, D., Yang, R., Dang, R., Jiang, P., Quantitative profiling of neurotransmitter abnormalities in the hippocampus of rats treated with lipopolysaccharide: Focusing on kynurenine pathway and implications for depression. J. Neuroimmunol. 295–296 (2016), 41–46, 10.1016/j.jneuroim.2016.04.006.
28. Heisler, J.M., O'Connor, J.C., Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory. Brain. Behav. Immun. 50 (2015), 115–124, 10.1016/j.bbi.2015.06.022.
29. Henry, C.J., Huang, Y., Wynne, A.M., Godbout, J.P., Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines. Brain. Behav. Immun. 23 (2009), 309–317, 10.1016/j.bbi.2008.09.002.
30. Hughes, M.M., Carballedo, A., McLoughlin, D.M., Amico, F., Harkin, A., Frodl, T., Connor, T.J., Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain. Behav. Immun. 26 (2012), 979–987, 10.1016/j.bbi.2012.05.010.
31. Jungblut, M., Tiveron, M.C., Barral, S., Abrahamsen, B., Knöbel, S., Pennartz, S., Schmitz, J., Perraut, M., Pfrieger, F.W., Stoffel, W., Cremer, H., Bosio, A., Isolation and characterization of living primary astroglial cells using the new GLAST-specific monoclonal antibody ACSA-1. Glia 60 (2012), 894–907, 10.1002/glia.22322.
32. Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., Nakamura, T., Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol. Brain, 2, 2009, 8, 10.1186/1756-6606-2-8.
33. Kanai, M., Nakamura, T., Funakoshi, H., Identification and characterization of novel variants of the tryptophan 2,3-dioxygenase gene: differential regulation in the mouse nervous system during development. Neurosci. Res. 64 (2009), 111–117, 10.1016/j.neures.2009.02.004.
34. Kennett, G.A., Joseph, M.H., The functional importance of increased brain tryptophan in the serotonergic response to restraint stress. Neuropharmacology 20 (1981), 39–43.
35. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S., The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA 289 (2003), 3095–3105, 10.1001/jama.289.23.3095.
36. Kim, H., Chen, L., Lim, G., Sung, B., Wang, S., McCabe, M.F., Rusanescu, G., Yang, L., Tian, Y., Mao, J., Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J. Clin. Invest. 122 (2012), 2940–2954, 10.1172/JCI61884.
37. Larkin, P.B., Sathyasaikumar, K.V., Notarangelo, F.M., Funakoshi, H., Nakamura, T., Schwarcz, R., Muchowski, P.J., Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice. Biochim. Biophys. Acta 1860 (2016), 2345–2354, 10.1016/j.bbagen.2016.07.002.
38. Lawson, M.A., Dostal, C.R., Brooks, A.K., McCusker, R.H., The kynurenine (Kyn) pathway and neuroinflammation: the confused brain. Opp, M.R., (eds.) Primer of PsychoneuroImmunology Research, 2016, Los Angeles, CA, 95–101.
39. Lawson, M., Parrott, J.M., McCusker, R.H., Dantzer, R., Kelley, K.W., O'Connor, J.C., Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J. Neuroinflammation, 10, 2013, 87, 10.1186/1742-2094-10-87.
40. Lestage, J., Verrier, D., Palin, K., Dantzer, R., The enzyme indoleamine 2, 3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav. Immun. 16 (2002), 596–601, 10.1016/S0889-1591(02)00014-4.
41. Liu, Y.-N., Peng, Y.-L., Lei-Liu, Wu, T.-Y., Zhang, Y., Lian, Y.-J., Yang, Y.-Y., Kelley, K.W., Jiang, C.-L., Wang, Y.-X., TNFα mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur. Cytokine Netw. 26 (2015), 15–25, 10.1016/j.rasd.2014.08.015.Social.
42. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001), 402–408, 10.1006/meth.2001.1262.
43. Martin, S., Dantzer, R., Kelley, K.W., Woods, J.A., Voluntary wheel running does not affect lipopolysaccharide-induced depressive-like behavior in young adult and aged mice. Neuroimmunomodulation 21 (2014), 52–63, 10.1159/000356144.
44. Matt, S.M., Lawson, M.A., Johnson, R.W., Aging and peripheral lipopolysaccharide can modulate epigenetic regulators and decrease IL-1b promoter DNA methylation in microglia. Neurobiol. Aging 47 (2016), 1–9, 10.1016/j.neurobiolaging.2016.07.006.
45. McCusker, R.H., Kavelaars, A., Heijnen, C.J., Dantzer, R., Kelley, K.W., Depression, Inflammation and Tryptophan Metabolism. Kusnecov, A., Anisman, H., (eds.) The Wiley-Blackwell Handbook of Psychoneuroimmunology, 2014, John Wiley & Sons, Ltd., 448–468.
46. McEwen, B.S., Bowles, N.P., Gray, J.D., Hill, M.N., Hunter, R.G., Karatsoreos, I.N., Nasca, C., Mechanisms of stress in the brain. Nat. Neurosci. 18 (2015), 1353–1363, 10.1038/nn.4086.
47. Merlo, L.M.F., Grabler, S., DuHadaway, J.B., Pigott, E., Manley, K., Prendergast, G.C., Laury-Kleintop, L.D., Mandik-Nayak, L., Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis. Clin. Immunol. 179 (2017), 8–16, 10.1016/j.clim.2017.01.016.
48. Merlo, L.M.F., Pigott, E., DuHadaway, J.B., Grabler, S., Metz, R., Prendergast, G.C., Mandik-Nayak, L., IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis. J. Immunol. 192 (2014), 2082–2090, 10.4049/jimmunol.1303012.
49. Metz, R., DuHadaway, J.B., Kamasani, U., Laury-Kleintop, L., Muller, A.J., Prendergast, G.C., Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67 (2007), 7082–7087, 10.1158/0008-5472.CAN-07-1872.
50. Metz, R., Smith, C., DuHadaway, J.B., Chandler, P., Baban, B., Merlo, L.M.F., Pigott, E., Keough, M.P., Rust, S., Mellor, A.L., Mandik-Nayak, L., Muller, A.J., Prendergast, G.C., IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int. Immunol. 26 (2014), 357–367, 10.1093/intimm/dxt073.
51. Miura, H., Ozaki, N., Sawada, M., Isobe, K., Ohta, T., Nagatsu, T., A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11 (2008), 198–209, 10.1080/10253890701754068.
52. Murray, M.F., The human indoleamine 2,3-dioxygenase gene and related human genes. Curr. Drug Metab. 8 (2007), 197–200, 10.2174/138920007780362509.
53. Myint, A.M., Kynurenines: from the perspective of major psychiatric disorders. FEBS J. 279 (2012), 1375–1385, 10.1111/j.1742-4658.2012.08551.x.
54. Myint, A.M., Schwarz, M.J., Müller, N., The role of the kynurenine metabolism in major depression. J. Neural Transm. 119 (2012), 245–251, 10.1007/s00702-011-0741-3.
55. Niimi, S., Nakamura, T., Nawa, K., Ichihara, A., Hormonal regulation of translatable mRNA of tryptophan 2,3-dioxygenase in primary cultures of adult rat hepatocytes. J. Biochem. 94 (1983), 1697–1706.
56. Nikodemova, M., Watters, J.J., Efficient isolation of live microglia with preserved phenotypes from adult mouse brain. J. Neuroinflammation, 9, 2012, 147, 10.1186/1742-2094-9-147.
57. Notarangelo, F.M., Schwarcz, R., Restraint stress during pregnancy rapidly raises kynurenic acid levels in mouse placenta and fetal brain. Dev. Neurosci., 2017 10.1159/000455228.
58. O'Connor, J.C., André, C., Wang, Y., Lawson, M., Szegedi, S.S., Lestage, J., Castanon, N., Kelley, K.W., Dantzer, R., Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J. Neurosci. 29 (2009), 4200–4209, 10.1523/JNEUROSCI.5032-08.2009.
59. O'Connor, J.C., Lawson, M.A., André, C., Briley, E.M., Szegedi, S.S., Lestage, J., Castanon, N., Herkenham, M., Dantzer, R., Kelley, K.W., Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. J. Immunol. 182 (2009), 3202–3212, 10.4049/jimmunol.0802722.
60. O'Connor, J.C., Lawson, M.A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K.W., Dantzer, R., Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 14 (2009), 511–522, 10.1038/sj.mp.4002148.
61. O'Farrell, K., Harkin, A., Stress-related regulation of the kynurenine pathway: relevance to neuropsychiatric and degenerative disorders. Neuropharmacology 112 (2017), 307–323, 10.1016/j.neuropharm.2015.12.004.
62. Ohira, K., Hagihara, H., Toyama, K., Takao, K., Kanai, M., Funakoshi, H., Nakamura, T., Miyakawa, T., Expression of tryptophan 2,3-dioxygenase in mature granule cells of the adult mouse dentate gyrus. Mol. Brain, 3, 2010, 26, 10.1186/1756-6606-3-26.
63. Pace, T.W.W., Hu, F., Miller, A.H., Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 21 (2007), 9–19, 10.1016/j.bbi.2006.08.009.
64. Pariante, C.M., Risk factors for development of depression and psychosis: glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann. N.Y. Acad. Sci. 1179 (2009), 144–152, 10.1111/j.1749-6632.2009.04978.x.
65. Pariante, C.M., The glucocorticoid receptor: part of the solution or part of the problem?. J. Psychopharmacol. 20 (2006), 79–84, 10.1177/1359786806066063.
66. Park, S.-E., Lawson, M., Dantzer, R., Kelley, K.W., McCusker, R.H., Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide. J. Neuroinflammation, 8, 2011, 179, 10.1186/1742-2094-8-179.
67. Parrott, J.M., Redus, L., O'Connor, J.C., Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge. J. Neuroinflammation 13 (2016), 1–15, 10.1186/s12974-016-0590-y.
68. Parrott, J.M., Redus, L., Santana-Coelho, D., Morales, J., Gao, X., O'Connor, J.C., Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation. Transl. Psychiatry 6 (2016), 1–12, 10.1038/tp.2016.200.
69. Pawlak, D., Takada, Y., Urano, T., Takada, A., Serotonergic and kynurenic pathways in rats exposed to foot shock. Brain Res. Bull. 52 (2000), 197–205, 10.1016/S0361-9230(00)00252-5.
70. Saito, K., Markey, S.P., Heyes, M.P., 6-Chloro-D, L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation. Neurosci. Lett. 178 (1994), 211–215.
71. Saito, K., Markey, S.P., Heyes, M.P., Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience 51 (1992), 25–39.
72. Salazar, A., Gonzalez-Rivera, B.L., Redus, L., Parrott, J.M., O'Connor, J.C., Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm. Behav. 62 (2012), 202–209, 10.1016/j.yhbeh.2012.03.010.
73. Savitz, J., Role of kynurenine metabolism pathway activation in major depressive disorders. Dantzer, R., Capuron, L., (eds.) Current Topics in Behavioral Neurosciences, 2016, Springer International Publishing, 249–267, 10.1007/7854_2016_12.
74. Savitz, J., Drevets, W.C., Wurfel, B.E., Ford, B.N., Bellgowan, P.S.F., Victor, T.A., Bodurka, J., Teague, T.K., Dantzer, R., Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain. Behav. Immun. 46 (2015), 55–59, 10.1016/j.bbi.2015.02.007.
75. Schinkel, A.H., Wagenaar, E., Van Deemtar, L., Mol, C.A.A.M., Borst, P., Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96 (1995), 1698–1705, 10.1172/JCI118214.
76. Schwarcz, R., 2016. Kynurenines and Glutamate: Multiple Links and Therapeutic Implications, first ed, Neuropsychopharmacology: A Tribute to Joseph T. Coyle. Elsevier Inc. 10.1016/bs.apha.2016.01.005.
77. Schwieler, L., Samuelsson, M., Frye, M.A., Bhat, M., Schuppe-Koistinen, I., Jungholm, O., Johansson, A.G., Landén, M., Sellgren, C.M., Erhardt, S., Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. J. Neuroinflammation, 13, 2016, 51, 10.1186/s12974-016-0517-7.
78. Soichot, M., Vaast, A., Vignau, J., Guillemin, G.J., Lhermitte, M., Broly, F., Allorge, D., Characterization of functional polymorphisms and glucocorticoid-responsive elements in the promoter of TDO2, a candidate gene for ethanol-induced behavioural disorders. Alcohol Alcohol. 48 (2013), 415–425, 10.1093/alcalc/agt028.
79. Souza, L.C., Jesse, C.R., Antunes, M.S., Ruff, J.R., de Oliveira Espinosa, D., Gomes, N.S., Donato, F., Giacomeli, R., Boeira, S.P., Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in mice. Brain. Behav. Immun. 56 (2016), 363–377, 10.1016/j.bbi.2016.03.002.
80. Streckfuss-Bomeke, K., Jende, J., Cheng, I.F., Hasenfuss, G., Guan, K., Efficient generation of hepatic cells from multipotent adult mouse germ-line stem cells using an OP9 co-culture system. Cell Reprogr. 16 (2014), 65–76, 10.1089/cell.2013.0057.
81. Talarowska, M., Galecki, P., Cognition and emotions in recurrent depressive disorders – the role of inflammation and the Kynurenine Pathway. Curr. Pharm. Des. 22 (2016), 1–8.
82. Trabanelli, S., Očadlíková, D., Ciciarello, M., Salvestrini, V., Lecciso, M., Jandus, C., Metz, R., Evangelisti, C., Laury-Kleintop, L., Romero, P., Prendergast, G.C., Curti, A., Lemoli, R.M., The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. J. Immunol. 192 (2014), 1231–1240, 10.4049/jimmunol.1300720.
83. Vecchiarelli, H.A., Gandhi, C.P., Hill, M.N., Acute psychological stress modulates the expression of enzymes involved in the Kynurenine Pathway throughout corticolimbic circuits in adult male rats. Neural Plast. 2016 (2015), 1–12, 10.1155/2016/7215684.
84. Wang, J., Dunn, A.J., The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1β. Brain Res. 815 (1999), 337–348, 10.1016/S0006-8993(98)01091-9.
85. Wang, Y., Lawson, M.A., Kelley, K.W., Dantzer, R., Primary murine microglia are resistant to nitric oxide inhibition of indoleamine 2,3-dioxygenase. Brain. Behav. Immun. 24 (2010), 1249–1253, 10.1016/j.bbi.2010.04.015.
86. Wang, Y., Lawson, M., Dantzer, R., Kelley, K.W., LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia. Brain. Behav. Immun. 24 (2010), 201–209, 10.1016/j.bbi.2009.06.152.
87. Wróbel, A., Serefko, A., Wlaź, P., Poleszak, E., The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice. Prog. Neuro-Psychopharmacology Biol. Psychiatry 54 (2014), 243–248, 10.1016/j.pnpbp.2014.06.008.
88. Wu, W., Nicolazzo, J.A., Wen, L., Chung, R., Stankovic, R., Bao, S.S., Lim, C.K., Brew, B.J., Cullen, K.M., Guillemin, G.J., Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PLoS One, 8, 2013, 10.1371/journal.pone.0059749.
89. Young, S.N., Mechanism of decline in rat brain 5-Hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis. Br. J. Pharmacol. 74 (1981), 695–700, 10.1111/j.1476-5381.1981.tb10480.x.
90. Yuasa, H.J., Takubo, M., Takahashi, A., Hasegawa, T., Noma, H., Suzuki, T., Evolution of vertebrate indoleamine 2,3-dioxygenases. J. Mol. Evol. 65 (2007), 705–714, 10.1007/s00239-007-9049-1.
91. Zhai, L., Dey, M., Lauing, K.L., Gritsina, G., Kaur, R., Lukas, R.V., Nicholas, M.K., Rademaker, A.W., Dostal, C.R., McCusker, R.H., Raizer, J.J., Parsa, A.T., Block, O., Wainwright, D.A., The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy. J. Clin. Neurosci. 22 (2015), 1964–1968.
92. Zhai, L., Ladomersky, E., Dostal, C.R., Lauing, K., Swoap, K., Billingham, L.K., Gritsina, G., Wu, M., McCusker, R.H., Binder, D.C., Wainwright, D.A., Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma. Brain. Behav. Immun. 62 (2017), 24–29, 10.1016/j.bbi.2017.01.022.
93. Zorrilla, E.P., Luborsky, L., McKay, J.R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D.A., Schmidt, K., The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain. Behav. Immun. 15 (2001), 199–226, 10.1006/brbi.2000.0597.